It is common for hospitals to mark up a drug’s cost 200 to 300 percent beyond what they initially pay to have it in stock, Anthem told the publication.
For specialty medications used to treat conditions like cancer and autoimmune disease, St. Elizabeth will limit the price to the cost of the drug plus a small fee to cover storage and handling, the Courier said.
The health system is the first to collaborate with Anthem on the initiative. The payer is working with other health systems on similar efforts, according to the Courier.
At the Becker's 5th Annual Fall Payer Issues Roundtable, taking place November 2–3 in Chicago, payer executives and healthcare leaders will come together to discuss value-based care, regulatory changes, cost management strategies and innovations shaping the future of payer-provider collaboration. Apply for complimentary registration now.
